Literature DB >> 15579303

Valproic acid doses, concentrations, and clearances in elderly nursing home residents.

Angela K Birnbaum1, Nancy A Hardie, Jeannine M Conway, Sandra E Bowers, Thomas E Lackner, Nina M Graves, Ilo E Leppik.   

Abstract

VPA daily dose and total VPA concentrations for 146 elderly (> or =65 years) nursing home residents collected from June 1998 to December 2000 in homes located throughout the United States are presented. Average age was 78.5+/-8.0 years old. The mean VPA daily dose was 16.2+/-11.2mg/kg and mean total VPA concentration was 48.5+/-24.8 mg/L. The majority (56.2%) of the VPA residents are being maintained at total VPA levels <50mg/L. Mean daily dose (19.4+/-11.4, 16.3+/-12.1, and 11.3+/-7.6 mg/kg/day; p=0.003) and total VPA concentration (56.4+/-25.8, 47.7+/-22.6, and 38.7+/-23.1mg/kg/day; p=0.003) decreased by age groups (65-74, 75-84, and > or =85 years). Daily dose and total VPA concentration were not different in residents receiving inhibitory or inducing co-medications, between men and women, or by albumin level. Total VPA clearance was similar between men and women, among age groups, or according to inducing or inhibiting co-medications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579303     DOI: 10.1016/j.eplepsyres.2004.08.009

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

1.  Antiseizure, antidepressant, and antipsychotic medication prescribing in elderly nursing home residents.

Authors:  Sai Praneeth R Bathena; Ilo E Leppik; Andres M Kanner; Angela K Birnbaum
Journal:  Epilepsy Behav       Date:  2017-02-24       Impact factor: 2.937

2.  Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly.

Authors:  Rebecca M Verellen; Jose E Cavazos
Journal:  Aging Dis       Date:  2011-08-30       Impact factor: 6.745

Review 3.  Epilepsy in the elderly.

Authors:  Ilo E Leppik; Angela K Birnbaum
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Variability of carbamazepine and valproate concentrations in elderly nursing home residents.

Authors:  Angela K Birnbaum; Jeannine M Conway; Melissa A Strege; Ilo E Leppik
Journal:  Epilepsy Res       Date:  2012-03-30       Impact factor: 3.045

5.  Pharmacokinetic Factors to Consider in the Selection of Antiseizure Drugs for Older Patients with Epilepsy.

Authors:  Gail D Anderson; Shahin Hakimian
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

6.  Apparent clearance of valproic acid in elderly epileptic patients: estimation of the confounding effect of albumin concentration.

Authors:  Natalia Lampon; J Carlos Tutor
Journal:  Ups J Med Sci       Date:  2011-12-29       Impact factor: 2.384

7.  Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.

Authors:  Chris M Bunce; Farhat L Khanim; Yao Jiang; Andrew D Southam; Sandro Trova; Flavio Beke; Bader Alhazmi; Thomas Francis; Anshul Radotra; Alessandro di Maio; Mark T Drayson
Journal:  Br J Cancer       Date:  2021-10-22       Impact factor: 7.640

8.  Comparison of Valproic acid Clearance between Epileptic Patients and Patients with Acute Mania.

Authors:  Amir Hooshang Mohammadpour; Mohsen Foroughipour; Mahmoud Reza Azarpazhooh; Mohammad Hasanzadeh Khayat; Saeed Rezaee; Tamara Aghebati; Jamal Shamsara
Journal:  Iran J Basic Med Sci       Date:  2011-11       Impact factor: 2.699

9.  Relationship between Patient Demographic Characteristics, Valproic Acid Dosage and Clearance in Adult Iranian Patients.

Authors:  Tamara Aghebati; Mohsen Foroughipour; Mahmoud Reza Azarpazhooh; Naghme Mokhber; Mohammad Hasanzadeh Khayat; Naser Vahdati; Amir Hooshang Mohammadpour
Journal:  Iran J Basic Med Sci       Date:  2012-03       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.